drugset / Trial / NCT00371813

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

NCT00371813

Phase 3 Completed 334 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate safety and efficacy of varenicline tartrate in helping people quit smoking

Timeline

Start
2006-09
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule

Indications

No indication recorded.